ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA found big problems a year ago at Chinese plant now recalling tainted valsartan
August 13, 2018An FDA inspection of the Zhejiang Huahai Pharmaceutical plant a year ahead of its global recall of tainted heart drug valsartan found a plant with little regard for quality control and which blamed out-of-specification test results on “ghost peaks,” lab e
Pharma Sources Insight January 2025
